MedPAC Sets Sights on Part D, Continuing Focus on Growth in Reinsurance Program Costs, Overall Program Reform

At today’s meeting, the Medicare Payment Advisory Commission (MedPAC) began their consideration of challenges facing the Medicare Part D prescription drug benefit, building up to a slate of recommendations to be included in their report to Congress later this year. Last year, the Commission approved several changes aimed at shifting more risk away from the […]